neutral
5 days agoTop Way Investors Track IPO Momentum: Corona Remedies Enters Final Day as GMP Rises to 25 Percent
Market participants are closely watching the final bidding session of Corona Remedies’ IPO as the pharmaceutical company’s public issue enters its last day on December 10. The IPO opened on December 8 and is priced between ₹1,008 and ₹1,062 per share, with the entire ₹655.37 crore issue structured as an offer for sale. A total of 0.62 crore equity shares are being divested by existing shareholders.
neutral
5 days agoTop Way Investors Track IPO Momentum: Corona Remedies Enters Final Day as GMP Rises to 25 Percent
Market participants are closely watching the final bidding session of Corona Remedies’ IPO as the pharmaceutical company’s public issue enters its last day on December 10. The IPO opened on December 8 and is priced between ₹1,008 and ₹1,062 per share, with the entire ₹655.37 crore issue structured as an offer for sale. A total of 0.62 crore equity shares are being divested by existing shareholders.
neutral
Top Way Investors Track IPO Momentum: Corona Remedies Enters Final Day as GMP Rises to 25 Percent
Recently
1 min read
66 words
Corona Remedies’ IPO reached its final bidding day with a 25 percent grey market premium as investors closely tracked demand and allotment prospects amid strong anchor participation.
Market participants are closely watching the final bidding session of Corona Remedies’ IPO as the pharmaceutical company’s public issue enters its last day on December 10. The IPO opened on December 8 and is priced between ₹1,008 and ₹1,062 per share, with the entire ₹655.37 crore issue structured as an offer for sale. A total of 0.62 crore equity shares are being divested by existing shareholders.
Market participants are closely watching the final bidding session of Corona Remedies’ IPO as the pharmaceutical company’s public issue enters its last day on December 10. The IPO opened on December 8 and is priced between ₹1,008 and ₹1,062 per share, with the entire ₹655.37 crore issue structured as an offer for sale. A total of 0.62 crore equity shares are being divested by existing shareholders.
Dec 10, 2025 • 09:48